Empagliflozin cut PA pressures in heart failure patientsOctober 12, 2020CardiologyPulmonologyEndocrinology
Psychosocial resilience associated with better cardiovascular health in BlacksOctober 7, 2020Mixed TopicsCardiology
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartanOctober 6, 2020CardiologyEndocrinology
AHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020CardiologyEndocrinology
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor useSeptember 25, 2020Mixed TopicsEndocrinologyCardiology
